Topical application/formulation of probiotics: Will it be a novel treatment approach for diabetic foot ulcer?

Medical Hypotheses

Volumn 82, Issue 1, 2014, Pages 86-88

  Sonal Sekhar, M ^a   Unnikrishnan, M K ^a   Vijayanarayana, K ^a   Rodrigues, Gabriel Sunil ^b   Mukhopadhyay, Chiranjay ^c  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b NMC SPECIALTY HOSPITAL   (United Arab Emirates)

^c KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; COLLAGEN; ELASTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; LIPOPROTEIN; LIPOTEICHOIC ACID; ORNITHINE; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL PROLIFERATION; CELL RESPIRATION; DECARBOXYLATION; DIABETIC FOOT; DIABETIC FOOT ULCER; DRUG FORMULATION; DRUG MECHANISM; ESCHERICHIA COLI; FOOT ULCER; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; KERATINOCYTE; LACTOBACILLUS RHAMNOSUS; LANGERHANS CELL; MOUTH; NOSE CAVITY; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STOMACH ULCER; THERAPY EFFECT; ULCER HEALING; UPREGULATION; WOUND HEALING;

ADMINISTRATION, TOPICAL; DIABETIC FOOT; HUMANS; MODELS, BIOLOGICAL; PROBIOTICS;

EID: 84890886423     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.11.013     Document Type: Article

References (12)

1. Twetman S. Are we ready for caries prevention through bacteriotherapy?. Braz Oral Res 2012, 26(Suppl. 1):64-70.
2. Leone S., Pascale R., Vitale M., Esposito S. Epidemiology of diabetic foot. Infez Med 2012, 20(Suppl. 1):8-13.
3. Oelschlaeger T.A. Mechanisms of probiotic actions - a review. Int J Med Microbiol 2010, 300(1):57-62.
4. Hickson M. Examining the evidence for the use of probiotics in clinical practice. Nurs Stand 2013, 27(29):35-41.
5. Singh Y., Ahmad J., Musarrat J., Ehtesham N.Z., Hasnain S.E. Emerging importance of holobionts in evolution and in probiotics. Gut Pathog 2013, 5(1):12.
6. Rao Y., Lingamneni B., Reddy D. Probiotics in oral health - a review. J N J Dent Assoc 2012, 83(2):28-32.
7. Meurman J.H. Probiotics: do they have a role in oral medicine and dentistry?. Eur J Oral Sci 2005, 113(3):188-196.
8. Huseini H.F., Rahimzadeh G., Fazeli M.R., Mehrazma M., Salehi M. Evaluation of wound healing activities of kefir products. Burns 2012, 38:719-723.
9. Hashimoto M., Tawaratsumida K., Kariya H., Aoyama K., Tamura T., Suda Y. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol 2006, 18(2):355-362.
10. Im E., Choi Y.J., Kim C.H., Fiocchi C., Pothoulakis C., Rohee S.H. The angiogenic effect of probiotic bacillus polyfermenticus on human intestinal microvascular endothelial cell is mediated by IL-8. Am J Physiol Gastrointest Liver Physiol 2009, 297:G999-G1008.
11. Lam E.K., Yu L., Wong H.P., Wu W.K., Shin V.Y., Tai E.K., et al. Probiotic Lactobacillus rhamnosus GG enhances gastric ulcer healing in rats. Eur J Pharmacol 2007, 565(1-3):171-179.
12. Dharmani P., De Simone C., Chadee K. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS One 2013, 8(3):e58671.